List of bibliographic references
Number of relevant bibliographic references: 61.
[40-60] [
0 - 20][
0 - 50][
60-60][
60-80]
| Ident. | Authors (with country if any) | Title |
|---|
| 001105 (2013) |
Suzanne Lesage [France] ; Mathieu Anheim ; Franck Letournel ; Luc Bousset ; Aurélie Honoré ; Nelly Rozas ; Laura Pieri ; Karine Madiona ; Alexandra Dürr ; Ronald Melki ; Christophe Verny ; Alexis Brice | G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. |
| 001212 (2013) |
Jonathan Chetrit [France] ; Anne Taupignon ; Lionel Froux ; Stephanie Morin ; Rabia Bouali-Benazzouz ; Frédéric Naudet ; Nabila Kadiri ; Christian E. Gross ; Bernard Bioulac ; Abdelhamid Benazzouz | Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease. |
| 001256 (2014) |
Carole Hyacinthe [France] ; Quentin Barraud [France] ; François Tison [France] ; Erwan Bezard [République populaire de Chine] ; Imad Ghorayeb [France] | D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism. |
| 001348 (2014) |
Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris | Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease. |
| 001710 (1989) |
M. Zreika [France] ; J R Fozard ; M W Dudley ; P. Bey ; I A Mcdonald ; M G Palfreyman | MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. |
| 001741 (2015) |
Hyung-Wook Kim [États-Unis, Corée du Sud] ; Won-Seok Choi [États-Unis, Corée du Sud] ; Noah Sorscher [États-Unis] ; Hyung Joon Park [Corée du Sud] ; François Tronche [France] ; Richard D. Palmiter [États-Unis] ; Zhengui Xia [États-Unis] | Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo |
| 001864 (2015) |
Robert A. Hauser [États-Unis] ; Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Susan B. Huyck [États-Unis] ; Rachel Capece [États-Unis] ; Tony W. Ho [États-Unis] ; Peter Sklar [États-Unis] ; Christopher Lines [États-Unis] ; David Michelson [États-Unis] ; David Hewitt [États-Unis] | Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned. |
| 001880 (2016) |
Sandra Dovero [France] ; Christian Gross [France] ; Erwan Bezard [France] | Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease? |
| 001890 (1989) |
J L Montastruc ; O. Rascol ; A. Rascol | A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. |
| 001904 (2016) |
Mathieu Schmitt [Belgique] ; Benjamin Dehay [France] ; Erwan Bezard [France] ; F Javier Garcia-Ladona [Belgique] | Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. |
| 001909 (2016) |
Clément François [États-Unis] ; Robert A. Hauser [États-Unis] ; Samuel Aballéa [France] ; Julie Dorey [États-Unis] ; Elizaveta Kharitonova [France] ; L Arthur Hewitt [États-Unis] | Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. |
| 001C99 (1994) |
P P Michel [France] ; S. Vyas ; P. Anglade ; M. Ruberg ; Yves Agid [France] | Morphological and molecular characterization of the response of differentiated PC12 cells to calcium stress. |
| 001D06 (1994) |
O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease. |
| 001D25 (1994) |
R. Marconi [France] ; D. Lefebvre-Caparros ; A M Bonnet ; M. Vidailhet ; B. Dubois ; Yves Agid [France] | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. |
| 001D68 (1993) |
D. Caparros-Lefebvre ; S. Blond ; P. Vermersch ; N. Pécheux ; J D Guieu ; H. Petit | Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. |
| 001D80 (1995) |
P. Limousin [France] ; P. Pollak ; A. Benazzouz ; D. Hoffmann ; E. Broussolle ; J E Perret ; A L Benabid | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. |
| 001E00 (1995) |
P. Limousin [France] ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E Perret | Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease. |
| 001E49 (1997) |
P. Limousin [France] ; B. Memin ; P. Pollak | Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin. |
| 001E64 (1997) |
N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L Montastruc | A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity. |
| 001E90 (1997) |
A. Boireau [France] ; F. Bordier ; P. Dubédat ; C. Pény ; A. Impérato | Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice. |
| 001F43 (1998) |
E. Bezard [France] ; J M Stutzmann ; C. Imbert ; T. Boraud ; A. Boireau ; C E Gross | Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dose-Response Relationship, Drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Dose-Response Relationship, Drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Dose-Response Relationship, Drug
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
